Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 43(2); 2011 > Article
Original Article Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008
Kyung Sook Lee, MS1, Dong Kwan Oh, MS1, Mi Ah Han, MD, PhD1, Hoo-Yeon Lee, MD, PhD1, Jae Kwan Jun, MD, PhD1, Kui Son Choi, MD, PhD1, Eun-Cheol Park, MD, PhD2
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2011;43(2):83-88.
DOI: https://doi.org/10.4143/crt.2011.43.2.83
Published online: June 30, 2011

1National Cancer Control Institute, National Cancer Center, Goyang, Korea.

2Department of Preventive Medicine and Institute of Health Service Research, Yonsei University College of Medicine, Seoul, Korea.

Correspondence: Jae Kwan Jun, MD, PhD. National Cancer Control Institute, National Cancer Center, Madu 1-dong, Ilsandong-gu, Goyang 410-769, Korea.
Tel: 82-31-920-2184, Fax: 82-31-920-2189, jkjun@ncc.re.kr
• Received: August 24, 2010   • Accepted: September 7, 2010

Copyright © 2011 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 12,858 Views
  • 89 Download
  • 74 Crossref
  • 81 Scopus
prev next
  • Purpose
    The National Cancer Screening Program (NCSP) began in 1999. The objective of this report is to evaluate the results of the NCSP in 2008 and provide essential evidence associated with the gastric cancer screening program in Korea.
  • Materials and Methods
    Data was obtained from the National Cancer Screening Information System; participation rates in gastric cancer screening were calculated. According to screening modalities, recall rates were estimated with 95% confidence intervals (CIs).
  • Results
    The target population of the gastric cancer screening program in 2008 was 7,132,820 Korean men and women aged 40 and over, 2,076,544 of whom underwent upper endoscopy or upper gastrointestinal (UGI) series as screening tools (participation rate, 29.1%). Disparities in participation rates were observed relating to gender and health insurance type. Overall, recall rates of upper endoscopy and UGI series were 3.1% (95% CI, 3.0 to 3.1) and 33.3% (95% CI, 33.3 to 33.4), respectively.
  • Conclusion
    According to our research, efforts to facilitate participation and to reduce disparities in gastric cancer screening among Korean men and women are needed. These results will provide essential data for evidence-based strategies in gastric cancer control in Korea.
Gastric cancer mortality has been decreasing continuously in Korea. It is, however, still a clinically important disease due to its high incidence and mortality [1,2]. To reduce high gastric cancer mortality, as part of a comprehensive 10-year plan for cancer control, the National Cancer Screening Program (NCSP) for Medical Aid Program (MAP) recipients was initiated in 1999. The NCSP recommends that men and women aged 40 or over undergo upper endoscopy or upper gastrointestinal (UGI) series every other year [3]. When a UGI series is chosen as a screening method, upper endoscopy can also be conducted if gastric cancer is suspected. If necessary, a biopsy is conducted during upper endoscopy.
The target population of NCSP was expanded to include National Health Insurance (NHI) beneficiaries within the lower 20% of the income bracket in 2002. This cut-off was increased to 30% in 2003 and then to 50% in 2005. Currently, MAP recipients and NHI beneficiaries in the lower 50% income bracket are eligible to be included in the NCSP and can have gastric cancer screening free of charge (including additional upper endoscopy and biopsy). The NHI Corporation has also provided gastric cancer screening to its beneficiaries who are not included in the NCSP and covers part of the cost of the screening services through the NHI screening program. It subsidized 50% of the cost of screening services until 2005. It subsequently increased its subsidization to 80% in 2006 and then to 90% in 2010.
The aim of this study was to evaluate results of the NCSP for gastric cancer in 2008, to investigate the participation rate of gastric cancer screening, and to assess the results.
Participants of the NCSP in 2008 were men and women who were NHI beneficiaries within the lower 50% of the income bracket and MAP recipients aged 40 or over, who were born in 1968 or before. For those who were included in the NCSP among the NHI beneficiaries, their insurance premium was US$56.5 (1 US$=1,000 won) per month or below (based on November, 2007) for the employee insured and US$67 per month or below for the self-employed insured.
Participation in the NCSP was confirmed from the claims and results of gastric cancer screening submitted to the NHI Corporation before December 31, 2009. Screening was performed between January 1, 2008 and December 31, 2008. Some subjects underwent the same screening procedure multiple times; for these individuals only the first screening was counted (n=2,239). Some subjects underwent UGI series followed by endoscopy because gastric cancer was suspected from the UGI series (n=5,719). These patients were only counted once to give the participation rate. The participation rate of gastric cancer screening was calculated by dividing the number of participants by the target population of NCSP for gastric cancer, and denoted as a percentile [4].
The results of the screening program were classified into six categories: 'normal,' 'benign,' 'needing further evaluation,' 'suspicious of cancer,' 'gastric cancer,' and 'confirmed gastric cancer.' 'Needing further evaluation' was defined as needed additional examination due to suspected gastric cancer, or the case where follow-up was required within a short period. 'Gastric cancer' was defined as a case where gastric cancer was confirmed in the biopsy during upper endoscopy. 'Confirmed gastric cancer' was defined as cases wherein the patient already has a previous medical history of gastric cancer prior to screening. In this study, participants falling within the categories 'needing further evaluation,' 'suspicious of cancer,' and 'gastric cancer' were deemed to be recall cases. Subjects who underwent both UGI series and upper endoscopy were defined as recall cases in UGI series regardless of the final result. Recall rates for gastric cancer screening were defined as the proportion of recall cases among the cancer-screened participants. The 95% confidence intervals were calculated for all outcome variables.
In the target population of 7,132,820 subjects for gastric cancer screening, there were 3,407,649 (47.8%) males and 3,725,171 (52.2%) females. Based on health insurance, 929,428 (13.0%) were covered by MAP and 6,203,392 (87.0%) were covered by NHI. There were 330,870 over the age of 70 covered by MAP, accounting for 35.6% of total MAP recipients. This was much higher than the 11% of NHI beneficiaries falling in the same age group.
Of the target population, 2,076,544 participants underwent gastric cancer screening, giving 29.1% participation. Of them, 58.6% (1,216,690) were women and 41.4% (859,854) were men. For men, there were 268,419 (31.2%) participants in their 50s, accounting for the largest male group, whereas, for women, the largest group was women in their 40s where there were 420,094 (34.5%) participants. For the NHI beneficiaries, participation decreased as their age increased, whereas, for MAP beneficiaries, participation increased as their age increased. Thus, there were 55,036 participants in their 70s, accounting for 32.1% of the total (Fig. 1).
According to screening method, 1,198,061 (57.7%) participants selected UGI series as a primary gastric cancer screening method, whereas 878,483 (42.3%) participants selected upper endoscopy. However, 385,062 subjects, (32.1%) who initially underwent UGI series, also underwent upper endoscopy. Of the participants in their 50s, 34.2% of the individuals who underwent UGI series also underwent upper endoscopy, accounting for the largest portion, whereas 28.9% of the participants in their 70s or over additionally underwent upper endoscopy, accounting for the smallest portion. For participants in their 40s, 335,087 (50.5%) underwent upper endoscopy, whereas 328,417 (49.5%) underwent UGI series. As age increased, the participation rate decreased so that 56,845 participants in their 70s underwent upper endoscopy, accounting for 22.4% of the total participants in their 70s who participated in the gastric cancer screening (Fig. 2).
The participation rate in gastric cancer screening in the 2008 NCSP was 29.1%. In the target population, the female participation rate was 32.7%, which was higher than the males with a rate of 25.2%. As participant age increased, so did the participation rate, to 39.7% in their 60s, which was the highest rate for both male and females (Fig. 3). This figure decreased to 25.0% in those in their 70s and over. When the participation rate was classified by insurance type, the participation rate was 18.5% in MAP recipients, which was lower than 30.7% in NHI beneficiaries (Fig. 4).
Of the 1,198,061 participants who underwent UGI series, 561,377 (46.9%) subjects were normal and 237,049 (19.8%) subjects were benign. The recall cases were classified as 12,575 (1.0%) 'needing further evaluation,' 386,634 (32.3%) 'suspicious of cancer,' and 127 (0.0%) as 'gastric cancer.' Of the total 878,483 participants who underwent upper endoscopy, 113,829 (13.0%) were normal and 737,427 (83.9%) were benign. The recall cases were classified as 24,014 (2.7%) 'needing further evaluation,' 1,138 (0.1%) 'suspicious of cancer,' and 1,798 (0.2%) as 'gastric cancer.' The recall rate for UGI series was 33.3%, with the highest rate of 34.1% for participants in their 40s. As participant age increased, the recall rate decreased, to 30.8%, the lowest rate being in participants aged 70 and over. The recall rate of upper endoscopy was 3.1%, which was lower than that of UGI series. As participant age increased, the recall rate increased (Table 1).
The participation rate in the NCSP for gastric cancer in 2008 was 29.1%. Trends for participation rates have been increasing continuously, from 12.7% in 2002 when the participation rate of gastric cancer screening in the NCSP was first estimated. However, it is still below the overall screening rate for gastric cancer in Korea (53.5%), including opportunistic screenings as well as the organized screening program conducted by the NHI Corporation [5].
In 1960, mass gastric screening by barium X-ray was started in Miyagi Prefecture, Japan. In conformity with the Law of Health and Medical Services for the Elderly, which came into effect in 1983, gastric cancer screening has been conducted nationwide as a Japanese government policy. Japanese men and women aged 40 or over were recommended to participate annually in cancer screening programs for gastric cancer with photofluorography using X-ray devices. Although the Japanese government set a goal of an annual participation rate of 30% among the target population, the participation rate in gastric cancer screening was 12.1% in 2006 [6-8].
In Korea, the participation rate in NCSP is higher than that of Japan, but is lower than the participation rate of 60-70% in European countries [9,10]. One reason that gastric cancer screening has not had a higher take-up in the NCSP was the negative perception that the quality of screening services was poor [11]. To facilitate participation in NCSP, many hospitals and clinics were allowed to become a gastric cancer screening facility if they met minimal requirements. This policy increased the participation rate in NCSP, but also caused an issue with the quality of the management of the cancer screening service.
To address this issue and improve the quality of cancer screening systematically, the government legislated for assessing and regulating cancer screening facilities via an amendment to the Cancer Control Act in 2006. The Quality Evaluation of National Cancer Screening (QENCS) program, which has been conducted by the National Cancer Center (NCC) since 2008, evaluates all aspect of cancer screening including the structure, process, and outcome. In particular, for outcome assessment, both participant satisfaction and the accuracy of cancer screening are reviewed. Prior to the assessment, the NCC developed and distributed 'Quality guidelines of gastric cancer screening' with the help of professional associations to improve the quality of gastric cancer screening. When the first term of the QENCS program, which is in progress, is completed for 2010, more objective and improved assessment items and standards will be developed.
The use of a photofluorographic device with 100 mm film will be prohibited in UGI series starting from 2010 to improve imaging quality. The standardized method of taking a series of films including 'supine positioned double contrast image,' 'prone positioned single contrast image,' 'erect compression image,' 'distal esophagus and gastroesophageal junction image,' and 'right posterior and left posterior oblique images (45°)' has been recommended since 2010. Although this lags the Japanese standardized method with the seven standard images [12], the standardization of UGI series and an improvement in screening performance can be expected as a result of this recommendation.
Despite the increasing trend in participation in NCSP for gastric cancer, there are some issues to be resolved. First, the incidence and mortality of gastric cancer are known to be relatively high in the lower socio-economic class in Korea [13]. Thus, the participation rate in gastric cancer screening needs to be improved in these people. However, the participation rate of MAP recipients increased from 12.6% in 2002 to 18.6% in 2008, which is lower than the rate of NHI beneficiaries (12.7% in 2002; 30.7% in 2008). Despite gastric cancer screening being free of charge, the poor participation rate of the socio-economic lower class in gastric cancer screening indicates other factors inhibit participation in gastric cancer screening apart from the economic burden of screening costs. Thus, identification of factors that inhibit participation in gastric cancer screening and suitable measures to overcome these are required.
Second, incidence rates of gastric cancer based on gender are 61.2 males/100,000 persons and 23.9 females/100,000 persons, 2.6-fold higher in males than females. Gastric cancer mortality is also 2.7-fold higher in males than females (age-adjusted mortality rate per 100,000, 25.3 in males and 9.3 in females) [2]. Despite the high incidence and mortality of gastric cancer in males, the male participation rate in gastric cancer screening is lower than for females (age-adjusted participation rate, 25.4% in males; 33.2% in females). Thus, to decrease high gastric cancer mortality, efforts should be made to increase the participation rate of gastric cancer screening in Korean men.
Third, compared with the recall rate of 3.1% in upper endoscopy, the recall rate was 33.3% in UGI series. This is attributable to the fact that 32.1% of the examinees who selected UGI series also underwent upper endoscopy. In the NCSP, if UGI series is chosen as a gastric cancer screening method, upper endoscopy can also be conducted free of charge. However, due to the ambiguous indication of additional upper endoscopy and free screening costs, unnecessary additional upper endoscopy is likely to be conducted.
In Japan, the recall rate of gastric cancer screening in Osaka was 11.7% in the 1970s [14], with a minimum of 10.1% and maximum of 18.9% in the 1980s [15-19]. Since the 1990s, the recall rate was recently reported to be approximately 10% [8,20]. At the beginning of gastric cancer screening programs in Japan, recall rates were as high as 20%, but decreased continuously to 10%, which has now stabilized. The category 'suspicious of cancer' will be clearly stated in the requirement of conducting additional upper endoscopy starting from 2010 in the NCSP, which should reduce unnecessary additional upper endoscopy.
The recall rate of upper endoscopy was 3.1%, maintaining the lower level, but disparities, depending on geographical location, were observed (age-adjusted recall rate range, 1.4 to 8.2%). In Korea, the qualification of doctors who can conduct endoscopy including the NCSP is not separately defined. In various foreign countries, to conduct endoscopy, doctors are required to take supervised training to reach a certain level of competence [21]. Additionally, to meet increased endoscopy demand and provide qualified services due to the introduction of a nationwide screening program using endoscopy, development of a new educational and training program is required [22]. The development of educational programs for endoscopists in the NCSP is required to minimize variations and to provide upper endoscopy at a consistent level.
Finally, there is the regional disparity of up to 11.6% in the participation rate, ranging from 23.3% to 34.9%. There was no change in the regional disparity even if the age was adjusted based on the region (age-adjusted participation rate range, 23.5 to 35.1%). According to the 2008 report, from a total of 249 regions across the country, 10 areas were reported to be without gastric cancer screening facilities (4.0%) [23]. In these areas, participants underwent gastric cancer screening in other areas or via mobile screening units.
In 2008, essentially required medical devices for gastric cancer screening were changed from 'endoscope' and 'photoflorographic apparatus' to 'endoscope' to improve access to gastric cancer screening. Through this modification, gastric cancer screening was available in clinics and hospitals equipped only with devices for upper endoscopy. Of the participants who underwent gastric cancer screening in 2008, 42.3% selected upper endoscopy as a screening tool. Considering additional upper endoscopy, more than half of the total participants underwent this procedure. However, 54.6% of the participants in Gyeonggi province underwent upper endoscopy for gastric cancer screening, whereas only 21.0% of the participants in Gangwon province underwent the same procedure. Regional disparities exist not only in the number of gastric cancer screening facilities but also in the number of hospitals and clinics that provide upper endoscopy. Thus, continuing efforts are required for more medical centers to participate in the NCSP, as well as investment in public hospitals to resolve areas with no screening unit.
In 2008, 29.1% of the target population of NCSP participated in gastric cancer screening. Differences in participation rate occurred between regions, age, and socioeconomic status. Additionally, differences existed in the selection of gastric cancer screening methods. Thus, along with improving the participation rate in gastric cancer screening, continuing efforts are required to minimize these differences.
Acknowledgements
This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1010201-1).

Conflict of interest relevant to this article was not reported.

  • 1. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009;41:122–131. PMID: 19809561ArticlePubMedPMCPDF
  • 2. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci. 2010;25:1113–1121. PMID: 20676319ArticlePubMedPMC
  • 3. Park CH. Proposal of a screening program for gastric cancer in Korea. J Korean Med Assoc. 2002;45:964–971. Article
  • 4. Perry N, Broeders M, de Wolf C, Tornberg S, Hölland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. 2006. 4th ed. Brussels: European Communities; p. 53–54.
  • 5. National Cancer CenterMinistry for Health Welfare and Family AffairsCancer facts and figures 2009. 2009. Goyang: National Cancer Center; p. 47–56.
  • 6. Ministry of Health, Labour and Welfare [Internet]. cited 2010 May 28Tokyo: Ministry of Health, Labour and Welfare; Available from: http://www.mhlw.go.jp/shingi/2004/04/s0427-2.html
  • 7. Health Statistics in Japan, 2007 [Internet]. cited 2010 May 28Tokyo: Ministry of Health, Labour and Welfare; Available from: http://www.mhlw.go.jp/english/database/db-hss/dl/hs2007a.pdf
  • 8. Ministry of Health, Labour and Welfare [Internet]. cited 2010 May 28Tokyo: Ministry of Health, Labour and Welfare; Available from: http://www.mhlw.go.jp/toukei/saikin/hw/c-hoken/06/r8.html
  • 9. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989;59:954–958. PMID: 2736233ArticlePubMedPMC
  • 10. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age: new results from the Swedish Two-County Trial. Cancer. 1995;75:2507–2517. PMID: 7736395ArticlePubMed
  • 11. Yoon NH, Lee HY, Kwak MS, Choi KS, Jun JK, Kim MK, et al. Comparison of satisfaction with cancer screening at mobile van and static sites: National Cancer Screening Program in Korea. Jpn J Clin Oncol. 2009;39:169–174. PMID: 19179364ArticlePubMed
  • 12. Hisamichi S. Screening for gastric cancer. World J Surg. 1989;13:31–37. PMID: 2658351ArticlePubMed
  • 13. Kim CW, Lee SY, Moon OR. Inequalities in cancer incidence and mortality across income groups and policy implications in South Korea. Public Health. 2008;122:229–236. PMID: 17935744ArticlePubMed
  • 14. Murakami R, Tsukuma H, Ubukata T, Nakanishi K, Fujimoto I, Kawashima T, et al. Estimation of validity of mass screening program for gastric cancer in Osaka, Japan. Cancer. 1990;65:1255–1260. PMID: 2302674ArticlePubMed
  • 15. Sugawara N, Hirasawa Y, Morimoto T, Sibuki S, Kogane T, Sato H, et al. An investigative report about health state of old age groups at first screening for gastric mass survey. J Gastroenterol Mass Surv. 1992;95:184–186.
  • 16. Fukao A, Hisamichi S, Takano A, Sugawara N. Accuracies of mass screening for gastric cancer-test sensitivity and program sensitivity. J Gatstroenterol Mass Surv. 1992;97:59–63.
  • 17. Sugahara N, Sibuki S, Hirasawa Y, Morimoto T. Characteristics of false negative cases. Stomach Intestine. 1991;26:1357–1362.
  • 18. Ishida T, Suematsu T, Oomayashi K, Takada Y, Kimura S, Suematsu C. Measurement of accuracy of stomach mass screening by population-based cancer registration. J Gastroenterol Mass Surv. 1994;32:9–16.
  • 19. Hattori M, Fujita M, Hosokawa O, Yamazaki S. A clinico-pathological evaluation of false negative cases in gastric cancer mass survey. J Gastroenterol Mass Surv. 1998;36:468–475.
  • 20. Abe S, Shibuya D, Noguchi T, Shimada T. An estimate of the false-negative rate of mass-screening for gastric carcinoma. J Gastroenterol Mass Surv. 2000;38:475–482.
  • 21. American Society for Gastrointestinal EndoscopyPrinciples of training in gastrointestinal endoscopy. From the ASGE. Gastrointest Endosc. 1999;49:845–853. PMID: 10343249PubMed
  • 22. Pentti M, Muller J, Janda M, Newman B. Views of supervisors of colonoscopy training on quality issues for the national bowel cancer screening program in Australia. J Gastroenterol Hepatol. 2009;24:209–213. PMID: 18823432ArticlePubMed
  • 23. National Cancer CenterDevelopment on evaluation of a comprehensive regional cancer center and operational framework for the specified regional cancer center. 0720620. 2008. Goyang: National Cancer Center; p. 160–163.
Fig. 1
Number of participants by health insurance type and age from the National Cancer Screening Program, 2008.
crt-43-83-g001.jpg
Fig. 2
Number of participants by screening modalities and age from the National Cancer Screening Program, 2008. UGI, upper gastrointestinal.
crt-43-83-g002.jpg
Fig. 3
Participation rates by gender and age from the National Cancer Screening Program, 2008.
crt-43-83-g003.jpg
Fig. 4
Participation rates by health insurance type and age from the National Cancer Screening Program, 2008.
crt-43-83-g004.jpg
Table 1
Screening outcomes by gender, health insurance type, age, and area of residence from the National Cancer Screening Program, 2008
Target population No. of participants Participation rate (%) UGI series Upper endoscopy


No. of participants Recall cases (n)a) Recall rate (%) 95% CI No. of participants Recall cases (n)b) Recall rate (%) 95% CI
Total 7,132,820 2,076,544 29.1 1,198,061 399,336 33.3 33.3-33.4 878,483 26,950 3.1 3.0-3.1
Gender
 Male 3,407,649 859,854 25.2 491,927 165,953 33.7 33.6-33.9 367,927 14,042 3.8 3.8-3.9
 Female 3,725,171 1,216,690 32.7 706,134 233,383 33.1 32.9-33.2 510,556 12,908 2.5 2.5-2.6
Health insurance type
 NHI 6,203,392 1,904,983 30.7 1,076,122 361,900 33.6 33.5-33.7 828,861 25,361 3.1 3.0-3.1
 MAP 929,428 171,561 18.5 121,939 37,436 30.7 30.4-31.0 49,622 1,589 3.2 3.1-3.4
Age group (yr)
 40-49 2,790,423 663,504 23.8 328,417 111,899 34.1 33.9-34.2 335,087 8,593 2.6 2.5-2.6
 50-59 2,066,304 658,276 31.9 359,931 126,648 35.2 35.0-35.3 298,345 9,060 3.0 3.0-3.1
 60-69 1,261,597 500,649 39.7 312,443 100,042 32.0 31.9-32.2 188,206 6,812 3.6 3.5-3.7
 ≥70 1,014,496 254,115 25.0 197,270 60,747 30.8 30.6-31.0 56,845 2,485 4.4 4.2-4.5
Residence area
 Seoul 1,290,766 332,469 25.8 165,412 41,400 25.0 24.8-25.2 167,057 6,424 3.8 3.8-3.9
 Busan 581,295 179,491 30.9 107,545 27,985 26.0 25.8-26.3 71,946 1,550 2.2 2.1-2.3
 Daegu 371,550 15,289 31.0 57,205 19,891 34.8 34.4-35.2 58,084 1,102 1.9 1.8-2.0
 Daejeon 183,722 62,213 33.9 35,531 13,636 38.4 37.9-38.9 26,682 614 2.3 2.1-2.5
 Incheon 398,470 92,676 23.3 48,653 11,435 23.5 23.1-23.9 44,023 3,256 7.4 7.2-7.6
 Gwangju 185,229 51,920 28.0 25,538 5,985 23.4 22.9-24.0 26,382 783 3.0 2.8-3.2
 Ulsan 121,576 30,615 25.2 17,102 4,570 26.7 26.1-27.4 13,513 239 1.8 1.6-2.0
 Gyeonggi 1,438,321 377,274 26.2 171,441 56,164 32.8 32.5-33.0 205,833 5,643 2.7 2.7-2.8
 Gangwon 259,406 86,326 33.3 68,227 33,896 49.7 49.3-50.1 18,099 457 2.5 2.3-2.8
 Chungcheongbuk 245,687 85,784 34.9 63,497 23,699 37.3 37.0-37.7 22,287 772 3.5 3.2-3.7
 Chungcheongnam 329,716 105,577 32.0 71,759 22,504 31.4 31.0-31.7 33,818 476 1.4 1.3-1.5
 Jeollabuk 328,079 108,692 33.1 74,807 23,922 32.0 31.6-32.3 33,885 998 2.9 2.8-3.1
 Jeollanam 363,882 122,251 33.6 75,693 20,330 26.9 26.5-27.2 46,558 1,486 3.2 3.0-3.4
 Gyeongsangbuk 459,180 150,775 32.8 96,816 48,051 49.6 49.3-50.0 53,959 1,627 3.0 2.9-3.2
 Gyeongsangnam 488,203 151,009 30.9 100,927 40,615 40.2 39.9-40.5 50,082 1,006 2.0 1.9-2.1
 Jeju 87,738 24,183 27.6 17,908 5,253 29.3 28.7-30.0 6,275 517 8.2 7.6-8.9

UGI, upper gastrointestinal; CI, confidence interval; NHI, National Health Insurance; MAP, Medical Aid Program. a)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' or received additional upper endoscopy for further evaluation after undergoing UGI series were deemed to be recall cases, b)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' were deemed to be recall cases.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Global burden, risk factors, clinicopathological characteristics, molecular biomarkers and outcomes of microsatellite instability-high gastric cancer
      Zhishan Zhang, Jinyuan Huang, Yingying Li, Huimeng Yan, Junxing Xie, Jing Wang, Bin Zhao
      Aging.2024;[Epub]     CrossRef
    • Endoscopic Submucosal Dissection in the Stomach and Duodenum
      Sarah S. Al Ghamdi, Saowanee Ngamruengphong
      Gastrointestinal Endoscopy Clinics of North America.2023; 33(1): 67.     CrossRef
    • A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?
      Wladyslaw Januszewicz, Maryla Helena Turkot, Peter Malfertheiner, Jaroslaw Regula
      Cancers.2023; 15(3): 664.     CrossRef
    • Determination of an Appropriate Endoscopic Monitoring Interval for Patients with Gastric Precancerous Conditions in China
      Kai Zhao, Li-na Feng, Su-hong Xia, Wang-dong Zhou, Ming-yu Zhang, Yu Zhang, Ruo-nan Dong, De-an Tian, Mei Liu, Jia-zhi Liao
      Current Medical Science.2023; 43(2): 268.     CrossRef
    • How to Improve the Efficacy of Gastric Cancer Screening?
      Wladyslaw Januszewicz, Maryla Helena Turkot, Jaroslaw Regula
      Current Treatment Options in Gastroenterology.2023; 21(3): 241.     CrossRef
    • Role of geographic characteristics in the spatial cluster detection of cancer: Evidence in South Korea, 1999–2013
      Insang Song, Eun-Hye Yoo, Inkyung Jung, Jin-Kyoung Oh, Sun-Young Kim
      Environmental Research.2023; 236: 116841.     CrossRef
    • Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
      Astrid E. Slagter, Irene A. Caspers, Nicole C. T. van Grieken, Iris Walraven, Pehr Lind, Elma Meershoek-Klein Kranenbarg, Cecile Grootscholten, Marianne Nordsmark, Johanna W. van Sandick, Karolina Sikorska, Cornelis J. H. van de Velde, Edwin P. M. Jansen,
      Cancers.2022; 14(12): 2963.     CrossRef
    • Chinese and Global Burdens of Gastrointestinal Cancers From 1990 to 2019
      Wangcheng Xie, Tingsong Yang, Jieliang Zuo, Zhilong Ma, Weidi Yu, Zhengyu Hu, Zhenshun Song
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: a systematic review and meta-analysis
      Sen Hou, Fan Liu, Zhidong Gao, Yingjiang Ye
      World Journal of Surgical Oncology.2022;[Epub]     CrossRef
    • Disparate and Alarming Impact of Gastrointestinal Cancers in Young Adult Patients
      Amir Khan, Philip H. G. Ituarte, Mustafa Raoof, Laleh Melstrom, Haiqing Li, Yate-Ching Yuan, Lily Lai, I. Benjamin Paz, Ajay Goel, Yuman Fong, Yanghee Woo
      Annals of Surgical Oncology.2021; 28(2): 785.     CrossRef
    • Implementation effect of institutional policy of EGD observation time on neoplasm detection
      Jae Myung Park, Sang Yoon Kim, Ga-Yeong Shin, Younghee Choe, Hyun Sun Cho, Chul-Hyun Lim, Yu Kyung Cho, Myung-Gyu Choi
      Gastrointestinal Endoscopy.2021; 93(5): 1152.     CrossRef
    • Periodic Fluctuations in the Incidence of Gastrointestinal Cancer
      Mun-Gan Rhyu, Jung-Hwan Oh, Tae Ho Kim, Joon-Sung Kim, Young A Rhyu, Seung-Jin Hong
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
      YoungJee Kim, Dong Wook Shin, Hyoung Woo Kim, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Gastric Cancer.2020; 23(3): 497.     CrossRef
    • Analysis of lymph node metastasis in early gastric cancer: a single institutional experience from China
      Jinggui Chen, Guangfa Zhao, Yanong Wang
      World Journal of Surgical Oncology.2020;[Epub]     CrossRef
    • Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
      Melina Arnold, Jin Young Park, M Constanza Camargo, Nuno Lunet, David Forman, Isabelle Soerjomataram
      Gut.2020; 69(5): 823.     CrossRef
    • Surveillance Endoscopy Guidelines for Postgastrectomy Patients Based on Risk of Developing Remnant Gastric Cancer
      Eui Soo Han, Ho Seok Seo, Ji Hyun Kim, Han Hong Lee
      Annals of Surgical Oncology.2020; 27(11): 4216.     CrossRef
    • Global burden of oesophageal and gastric cancer by histology and subsite in 2018
      Melina Arnold, Jacques Ferlay, Mark I van Berge Henegouwen, Isabelle Soerjomataram
      Gut.2020; 69(9): 1564.     CrossRef
    • Towards Personalization in the Curative Treatment of Gastric Cancer
      Astrid E. Slagter, Marieke A. Vollebergh, Edwin P. M. Jansen, Johanna W. van Sandick, Annemieke Cats, Nicole C. T. van Grieken, Marcel Verheij
      Frontiers in Oncology.2020;[Epub]     CrossRef
    • Community-Based Pilot Study of a Screening Program for Gastric Cancer in a Chinese Population
      Lin Ji, Zengchao Liu, Bin Zhou, Ying Cai, Fangmei An, Lei Wang, Zhifa Lv, Min Xia, Jianbo Yang, Jianfen Yuan, Hui Wang, Zhiyi Zhou, Shudong Yang, Lei Hu, Qiang Zhan
      Cancer Prevention Research.2020; 13(1): 73.     CrossRef
    • The incidence of lymph node metastasis in submucosal early gastric cancer according to the expanded criteria: a systematic review
      Mohamed M. Abdelfatah, Mohamed Barakat, Mohamed O. Othman, Ian S. Grimm, Noriya Uedo
      Surgical Endoscopy.2019; 33(1): 26.     CrossRef
    • Efficacy and safety of endoscopic submucosal dissection for gastric epithelial neoplasia in elderly patients aged 80 years and older
      Young Woong Son, Ain Kim, Han Ho Jeon
      Aging Clinical and Experimental Research.2019; 31(12): 1833.     CrossRef
    • Quality of Life in Vietnamese Gastric Cancer Patients
      Dzung Ngoc Thi Dang, Lan Ngoc Thi Nguyen, Nga Thi Dang, Huy Quang Dang, Thanh Van Ta
      BioMed Research International.2019; 2019: 1.     CrossRef
    • The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis
      Mohamed M. Abdelfatah, Mohamed Barakat, Hyuk Lee, Jae J. Kim, Noriya Uedo, Ian Grimm, Mohamed O. Othman
      Gastrointestinal Endoscopy.2018; 87(2): 338.     CrossRef
    • Aplicación de la endoscopia sistemática alfanumérica codificada más cromoendoscopia para la detección de lesiones precancerosas gástricas y cáncer gástrico temprano en sujetos con riesgo promedio de cáncer gástrico
      A. Pérez-Mendoza, Á.M. Zárate-Guzmán, E.S. Galvis García, S. Sobrino Cossío, J. Djamus Birch
      Revista de Gastroenterología de México.2018; 83(2): 117.     CrossRef
    • Non‐alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study
      Yang Won Min, Youngha Kim, Geum‐Youn Gwak, Seonhye Gu, Danbee Kang, Soo Jin Cho, Eliseo Guallar, Juhee Cho, Dong Hyun Sinn
      Journal of Gastroenterology and Hepatology.2018; 33(5): 1053.     CrossRef
    • Endoscopic Treatment for Esophageal Cancer
      Yang Won Min
      The Korean Journal of Gastroenterology.2018; 71(3): 116.     CrossRef
    • The Effect ofHelicobacter pyloriInfection on the Recurrence of Gastric Hyperplastic Polyp
      Su Youn Nam
      The Korean Journal of Gastroenterology.2018; 71(4): 183.     CrossRef
    • Effect of Helicobacter pylori eradication on the regression of gastric polyps in National Cancer Screening Program
      Su Youn Nam, Bum Joon Park, Kum Hei Ryu, Ji Hyung Nam
      The Korean Journal of Internal Medicine.2018; 33(3): 506.     CrossRef
    • Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes
      Byeong Geun Song, Yang Won Min, Ra Ri Cha, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jae J. Kim
      BMC Gastroenterology.2018;[Epub]     CrossRef
    • Systematic alphanumeric-coded endoscopy versus chromoendoscopy for the detection of precancerous gastric lesions and early gastric cancer in subjects at average risk for gastric cancer
      A. Pérez-Mendoza, Á.M. Zárate-Guzmán, E.S. Galvis García, S. Sobrino Cossío, J. Djamus Birch
      Revista de Gastroenterología de México (English Edition).2018; 83(2): 117.     CrossRef
    • Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up
      Liming Zhang, Yulan Liu, Peng You, Guijian Feng
      Scandinavian Journal of Gastroenterology.2018; 53(7): 843.     CrossRef
    • Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis
      Yang Won Min, Hyuk Lee, Byeong Geun Song, Byung-Hoon Min, Hong Kwan Kim, Yong Soo Choi, Jun Haeng Lee, Na-Young Hwang, Keumhee C. Carriere, Poong-Lyul Rhee, Jae J. Kim, Jae Ill Zo, Young Mog Shim
      Gastrointestinal Endoscopy.2018; 88(4): 624.     CrossRef
    • Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer
      Feng Li, Janice M Yoshizawa, Kyoung-Mee Kim, Julie Kanjanapangka, Tristan R Grogan, Xiaoyan Wang, David E Elashoff, Shigeo Ishikawa, David Chia, Wei Liao, David Akin, Xinmin Yan, Min-Sun Lee, Rayun Choi, Su-Mi Kim, So-Young Kang, Jae-Moon Bae, Tae-Sung So
      Clinical Chemistry.2018; 64(10): 1513.     CrossRef
    • Endoscopic prediction model for differentiating upper submucosal invasion (< 200 μm) and beyond in superficial esophageal squamous cell carcinoma
      Joohwan Bae, In Seub Shin, Yang Won Min, Insuk Sohn, Joong Hyun Ahn, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jae J. Kim
      Oncotarget.2018; 9(10): 9156.     CrossRef
    • Differences in upper gastrointestinal neoplasm detection rates based on inspection time and esophagogastroduodenoscopy training
      Shoichi Yoshimizu, Toshiaki Hirasawa, Yusuke Horiuchi, Masami Omae, Akiyoshi Ishiyama, Toshiyuki Yoshio, Tomohiro Tsuchida, Junko Fujisaki
      Endoscopy International Open.2018; 06(10): E1190.     CrossRef
    • Endoscopic Management of Early Gastric Adenocarcinoma and Preinvasive Gastric Lesions
      Saowanee Ngamruengphong, Seiichiro Abe, Ichiro Oda
      Surgical Clinics of North America.2017; 97(2): 371.     CrossRef
    • Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality
      Jae Kwan Jun, Kui Son Choi, Hoo-Yeon Lee, Mina Suh, Boyoung Park, Seung Hoon Song, Kyu Won Jung, Chan Wha Lee, Il Ju Choi, Eun-Cheol Park, Dukhyoung Lee
      Gastroenterology.2017; 152(6): 1319.     CrossRef
    • Evaluation of Transabdominal Ultrasound with Oral Cellulose-Based Contrast Agent in the Detection and Surveillance of Gastric Ulcer
      Zhijun Liu, Jintao Guo, Shupeng Wang, Ying Zhao, Zhining Liu, Jing Li, Weidong Ren, Shaoshan Tang, Limei Xie, Ying Huang, Siyu Sun, Liping Huang
      Ultrasound in Medicine & Biology.2017; 43(7): 1364.     CrossRef
    • Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy
      Jae Myung Park, Sol Mi Huo, Han Hee Lee, Bo-In Lee, Ho Jin Song, Myung-Gyu Choi
      Gastroenterology.2017; 153(2): 460.     CrossRef
    • Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy
      Ji Hyun Song, Sang Gyun Kim, Eun Hyo Jin, Joo Hyun Lim, Sun Young Yang
      Gut and Liver.2017; 11(5): 612.     CrossRef
    • Belching during gastroscopy and its association with gastroesophageal reflux disease
      B. S. Lee, S. H. Lee, D. K. Jang, K. H. Chung, J. H. Hwang, S. E. Jang, B. H. Cha, J. K. Ryu, Y.-T. Kim
      Diseases of the Esophagus.2016; 29(4): 342.     CrossRef
    • Endoscopic and oncologic outcomes according to indication criteria of endoscopic resection for early gastric cancer: a systematic review and meta-analysis
      Se Woo Park, Hyuk Lee, Chan Hyuk Park, Hyun Joo Jang, Hongyup Ahn
      Surgical Endoscopy.2016; 30(4): 1270.     CrossRef
    • The risk of lymph node metastases in 3951 surgically resected mucosal gastric cancers: implications for endoscopic resection
      Kang Kook Choi, Jae Moon Bae, Su Mi Kim, Tae Sung Sohn, Jae Hyung Noh, Jun Ho Lee, Min-Gew Choi, Sung Kim
      Gastrointestinal Endoscopy.2016; 83(5): 896.     CrossRef
    • The Influence of Gastric Cancer Screening on the Stage at Diagnosis and Survival
      Esha Khanderia, Sheraz R. Markar, Amish Acharya, Yeol Kim, Young-Woo Kim, George B. Hanna
      Journal of Clinical Gastroenterology.2016; 50(3): 190.     CrossRef
    • Differences in routine esophagogastroduodenoscopy between Japanese and international facilities: A questionnaire survey
      Noriya Uedo, Takuji Gotoda, Shigetaka Yoshinaga, Tokuma Tanuma, Yoshinori Morita, Hisashi Doyama, Akira Aso, Toshiaki Hirasawa, Tomonori Yano, Norihisa Uchita, Shiaw‐Hooi Ho, Ping‐Hsin Hsieh
      Digestive Endoscopy.2016; 28(S1): 16.     CrossRef
    • Current Perspectives on Gastric Cancer
      Juan M. Marqués-Lespier, María González-Pons, Marcia Cruz-Correa
      Gastroenterology Clinics of North America.2016; 45(3): 413.     CrossRef
    • Meta‐analysis of confocal laser endomicroscopy for the diagnosis of gastric neoplasia and adenocarcinoma
      Wei Qian, Tao Bai, Huan Wang, Lei Zhang, Jun Song, Xiao Hua Hou
      Journal of Digestive Diseases.2016; 17(6): 366.     CrossRef
    • Endoscopic Submucosal Dissection Outcomes for Gastroesophageal Tumors in Low Volume Units: A Multicenter Survey
      Ahmad Najib Azmi, Christopher J. L. Khor, Khek-Yu Ho, Rapat Pittayanon, Rungsun Rerknimitr, Thawee Ratanachu-ek, Doreen S. C. Koay, Jianyi Calvin Koh, Shiaw-Hooi Ho, Khean-Lee Goh, Sanjiv Mahadeva
      Diagnostic and Therapeutic Endoscopy.2016; 2016: 1.     CrossRef
    • Cost Comparison between Surgical Treatments and Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer in Korea
      Younhee Kim, Young-Woo Kim, Il Ju Choi, Joo Young Cho, Jong Hee Kim, Jin-Won Kwon, Ja Youn Lee, Na Rae Lee, Sang-Yong Seol
      Gut and Liver.2015; 9(2): 174.     CrossRef
    • Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine
      Yoon Young Choi, Sung Hoon Noh, Jae-Ho Cheong
      Yonsei Medical Journal.2015; 56(5): 1177.     CrossRef
    • Antifungal Treatment is Not Required for Immunocompetent Individuals With Asymptomatic Esophageal Candidiasis
      Yang Won Min, Eun Kim, Hee Jung Son, Jae J. Kim, Poong-Lyul Rhee
      Medicine.2015; 94(45): e1969.     CrossRef
    • Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for gastric cancer
      Zhijun Liu, Jintao Guo, Shupeng Wang, Ying Zhao, Jing Li, Weidong Ren, Shaoshan Tang, Limei Xie, Ying Huang, Siyu Sun, Liping Huang
      BMC Cancer.2015;[Epub]     CrossRef
    • Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer
      Min Jung Jo
      World Journal of Gastroenterology.2015; 21(2): 667.     CrossRef
    • ESD Around the World: United States
      Norio Fukami
      Gastrointestinal Endoscopy Clinics of North America.2014; 24(2): 313.     CrossRef
    • Screening of Gastric Cancer: Who, When, and How
      Jaw–Town Lin
      Clinical Gastroenterology and Hepatology.2014; 12(1): 135.     CrossRef
    • Endoscopic Resection for Early Gastric Cancer beyond Absolute Indication with Emphasis on Controversial Issues
      Yang Won Min, Jun Haeng Lee
      Journal of Gastric Cancer.2014; 14(1): 7.     CrossRef
    • Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for demonstrating small gastric subepithelial masses
      Zhijun Liu, Jintao Guo, Siyu Sun, Weidong Ren, Shaoshan Tang, Limei Xie, Liping Huang
      Abdominal Imaging.2014; 39(2): 424.     CrossRef
    • Implementation of gastric cancer screening – The global experience
      Mārcis Leja, Weicheng You, M. Constanza Camargo, Hiroshi Saito
      Best Practice & Research Clinical Gastroenterology.2014; 28(6): 1093.     CrossRef
    • Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups
      Il Ju Choi
      Clinical Endoscopy.2014; 47(6): 497.     CrossRef
    • Barriers to Cancer Screening among Medical Aid Program Recipients in the Republic of Korea: A Qualitative Study
      Yoon Young Lee, Jae Kwan Jun, Mina Suh, BoYoung Park, Yeol Kim, Kui Son Choi
      Asian Pacific Journal of Cancer Prevention.2014; 15(2): 589.     CrossRef
    • D1 versus D2 lymphadenectomy for gastric cancer
      Benjamin Schmidt, Sam S. Yoon
      Journal of Surgical Oncology.2013; 107(3): 259.     CrossRef
    • Staging of intestinal‐ and diffuse‐type gastric cancers with theOLGAandOLGIMstaging systems
      S.‐J. Cho, I. J. Choi, M.‐C. Kook, B.‐H. Nam, C. G. Kim, J. Y. Lee, K. W. Ryu, Y.‐W. Kim
      Alimentary Pharmacology & Therapeutics.2013; 38(10): 1292.     CrossRef
    • Outcomes and Efficiency of National Gastric Cancer Screening Program in Korea
      Sang Wook Lee, Beom Jin Kim, Jung Duck Park, Jae Gyu Kim
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2013; 13(2): 95.     CrossRef
    • Cost-effectiveness Outcomes of the National Gastric Cancer Screening Program in South Korea
      Eun Cho, Moon Hae Kang, Kui Son Choi, MiNa Suh, Jae Kwan Jun, Eun-Cheol Park
      Asian Pacific Journal of Cancer Prevention.2013; 14(4): 2533.     CrossRef
    • Current evidence of effects ofHelicobacter pylorieradication on prevention of gastric cancer
      Il Ju Choi
      The Korean Journal of Internal Medicine.2013; 28(5): 525.     CrossRef
    • Discrimination of gastric cancer from normal by serum RNA based on surface‐enhanced Raman spectroscopy (SERS) and multivariate analysis
      Yanping Chen, Gang Chen, Xiongwei Zheng, Cheng He, Shangyuan Feng, Yan Chen, Xiaoqian Lin, Rong Chen, Haisan Zeng
      Medical Physics.2012; 39(9): 5664.     CrossRef
    • Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2011
      Boyoung Park, Kui Son Choi, Yoon Young Lee, Jae Kwan Jun, Hong Gwan Seo
      Cancer Research and Treatment.2012; 44(2): 113.     CrossRef
    • U.S. Geriatricians and Gastric Cancer Screening in Elderly Korean‐American Men: Differences from Korean Geriatricians
      Chang Won Won, Hwan‐Sik Hwang
      Journal of the American Geriatrics Society.2012; 60(5): 996.     CrossRef
    • Effectiveness of Interventions to Increase the Participation Rate of Gastric Cancer Screening in the Republic of Korea: a Pilot study
      Myung-Ha Lee, Yoon-Young Lee, Da-Won Jung, Bo-Young Park, E-Hwa Yun, Hoo-Yeon Lee, Jae-Kwan Jun, Kui-Son Choi
      Asian Pacific Journal of Cancer Prevention.2012; 13(3): 861.     CrossRef
    • Endoscopist Specialty Is Associated with High-Quality Endoscopy in Korea
      Jae Myung Cha, Dong Soo Han, Hang Lack Lee, Young Ho Kim, Il-Kwun Chung, Hyun Soo Kim, Jeong Seop Moon, Yu Kyung Cho
      Yonsei Medical Journal.2012; 53(2): 310.     CrossRef
    • Cancer Screening Status in Korea, 2011: Results from the Korean National Cancer Screening Survey
      Bo-Young Park, Kui-Son Choi, Yoon-Young Lee, Jae-Kwan Jun, Hong-Gwan Seo
      Asian Pacific Journal of Cancer Prevention.2012; 13(4): 1187.     CrossRef
    • Current Management and Future Strategies of Gastric Cancer
      Joong Ho Lee, Kyung Min Kim, Jae-Ho Cheong, Sung Hoon Noh
      Yonsei Medical Journal.2012; 53(2): 248.     CrossRef
    • Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population
      Amir Abadir, Catherine Streutker, Christine Brezden-Masley, Andrea Grin, Young-In Kim
      Clinical Medicine Insights: Gastroenterology.2012; 5: CGast.S10070.     CrossRef
    • Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010
      Eun-Ha Lee, Hoo-Yeon Lee, Kui Son Choi, Jae Kwan Jun, Eun-Cheol Park, Jin Soo Lee
      Cancer Research and Treatment.2011; 43(3): 141.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008
      Cancer Res Treat. 2011;43(2):83-88.   Published online June 30, 2011
      Close
    • XML DownloadXML Download
    Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008
    Image Image Image Image
    Fig. 1 Number of participants by health insurance type and age from the National Cancer Screening Program, 2008.
    Fig. 2 Number of participants by screening modalities and age from the National Cancer Screening Program, 2008. UGI, upper gastrointestinal.
    Fig. 3 Participation rates by gender and age from the National Cancer Screening Program, 2008.
    Fig. 4 Participation rates by health insurance type and age from the National Cancer Screening Program, 2008.
    Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008
    Target population No. of participants Participation rate (%) UGI series Upper endoscopy


    No. of participants Recall cases (n)a) Recall rate (%) 95% CI No. of participants Recall cases (n)b) Recall rate (%) 95% CI
    Total 7,132,820 2,076,544 29.1 1,198,061 399,336 33.3 33.3-33.4 878,483 26,950 3.1 3.0-3.1
    Gender
     Male 3,407,649 859,854 25.2 491,927 165,953 33.7 33.6-33.9 367,927 14,042 3.8 3.8-3.9
     Female 3,725,171 1,216,690 32.7 706,134 233,383 33.1 32.9-33.2 510,556 12,908 2.5 2.5-2.6
    Health insurance type
     NHI 6,203,392 1,904,983 30.7 1,076,122 361,900 33.6 33.5-33.7 828,861 25,361 3.1 3.0-3.1
     MAP 929,428 171,561 18.5 121,939 37,436 30.7 30.4-31.0 49,622 1,589 3.2 3.1-3.4
    Age group (yr)
     40-49 2,790,423 663,504 23.8 328,417 111,899 34.1 33.9-34.2 335,087 8,593 2.6 2.5-2.6
     50-59 2,066,304 658,276 31.9 359,931 126,648 35.2 35.0-35.3 298,345 9,060 3.0 3.0-3.1
     60-69 1,261,597 500,649 39.7 312,443 100,042 32.0 31.9-32.2 188,206 6,812 3.6 3.5-3.7
     ≥70 1,014,496 254,115 25.0 197,270 60,747 30.8 30.6-31.0 56,845 2,485 4.4 4.2-4.5
    Residence area
     Seoul 1,290,766 332,469 25.8 165,412 41,400 25.0 24.8-25.2 167,057 6,424 3.8 3.8-3.9
     Busan 581,295 179,491 30.9 107,545 27,985 26.0 25.8-26.3 71,946 1,550 2.2 2.1-2.3
     Daegu 371,550 15,289 31.0 57,205 19,891 34.8 34.4-35.2 58,084 1,102 1.9 1.8-2.0
     Daejeon 183,722 62,213 33.9 35,531 13,636 38.4 37.9-38.9 26,682 614 2.3 2.1-2.5
     Incheon 398,470 92,676 23.3 48,653 11,435 23.5 23.1-23.9 44,023 3,256 7.4 7.2-7.6
     Gwangju 185,229 51,920 28.0 25,538 5,985 23.4 22.9-24.0 26,382 783 3.0 2.8-3.2
     Ulsan 121,576 30,615 25.2 17,102 4,570 26.7 26.1-27.4 13,513 239 1.8 1.6-2.0
     Gyeonggi 1,438,321 377,274 26.2 171,441 56,164 32.8 32.5-33.0 205,833 5,643 2.7 2.7-2.8
     Gangwon 259,406 86,326 33.3 68,227 33,896 49.7 49.3-50.1 18,099 457 2.5 2.3-2.8
     Chungcheongbuk 245,687 85,784 34.9 63,497 23,699 37.3 37.0-37.7 22,287 772 3.5 3.2-3.7
     Chungcheongnam 329,716 105,577 32.0 71,759 22,504 31.4 31.0-31.7 33,818 476 1.4 1.3-1.5
     Jeollabuk 328,079 108,692 33.1 74,807 23,922 32.0 31.6-32.3 33,885 998 2.9 2.8-3.1
     Jeollanam 363,882 122,251 33.6 75,693 20,330 26.9 26.5-27.2 46,558 1,486 3.2 3.0-3.4
     Gyeongsangbuk 459,180 150,775 32.8 96,816 48,051 49.6 49.3-50.0 53,959 1,627 3.0 2.9-3.2
     Gyeongsangnam 488,203 151,009 30.9 100,927 40,615 40.2 39.9-40.5 50,082 1,006 2.0 1.9-2.1
     Jeju 87,738 24,183 27.6 17,908 5,253 29.3 28.7-30.0 6,275 517 8.2 7.6-8.9
    Table 1 Screening outcomes by gender, health insurance type, age, and area of residence from the National Cancer Screening Program, 2008

    UGI, upper gastrointestinal; CI, confidence interval; NHI, National Health Insurance; MAP, Medical Aid Program. a)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' or received additional upper endoscopy for further evaluation after undergoing UGI series were deemed to be recall cases, b)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' were deemed to be recall cases.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP